Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model

Liver fibrosis occurring as an outcome of non-alcoholic steatohepatitis (NASH) can precede the development of cirrhosis. We investigated the effects of sorafenib in preventing liver fibrosis in a rodent model of NASH. Adult Sprague-Dawley rats were fed a choline-deficient high-fat diet and exposed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefano, J.T., Pereira, I.V.A., Torres, M.M., Bida, P.M., Coelho, A.M.M., Xerfan, M.P., Cogliati, B., Barbeiro, D.F., Mazo, D.F.C., Kubrusly, M.S., D'Albuquerque, L.A.C., Souza, H.P., Carrilho, F.J., Oliveira, C.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2015
Materias:
Biomedical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445663/
https://www.ncbi.nlm.nih.gov/pubmed/25714891
http://dx.doi.org/10.1590/1414-431X20143962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445663/
https://www.ncbi.nlm.nih.gov/pubmed/25714891
http://dx.doi.org/10.1590/1414-431X20143962

Ejemplares similares